These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 15217488)

  • 1. Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer.
    Gee JM; Giles MG; Nicholson RI
    Breast Cancer Res; 2004; 6(4):162-3. PubMed ID: 15217488
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
    Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
    Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins.
    Ivankovic-Dikic I; Grönroos E; Blaukat A; Barth BU; Dikic I
    Nat Cell Biol; 2000 Sep; 2(9):574-81. PubMed ID: 10980697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
    Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
    Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
    Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model.
    Staka CM; Nicholson RI; Gee JM
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S85-97. PubMed ID: 16113102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity.
    Wang LH; Yang XY; Zhang X; Mihalic K; Xiao W; Farrar WL
    Cancer Res; 2003 May; 63(9):2046-51. PubMed ID: 12727818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
    Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
    Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM; Dong S; Fan M; Li JJ
    Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide regulates oestrogen-activated signalling pathways at multiple levels through cyclic GMP-dependent recruitment of insulin receptor substrate 1.
    Falcone S; Mauro L; de Rose G; Paolucci C; Sciorati C; Ando S; Clementi E
    Biochem J; 2002 Aug; 366(Pt 1):165-73. PubMed ID: 11978177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.
    Driggers PH; Segars JH
    Trends Endocrinol Metab; 2002 Dec; 13(10):422-7. PubMed ID: 12431838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplifying signal transduction specificity without multiple phosphorylation.
    Qian H
    Biophys J; 2003 Feb; 84(2 Pt 1):1410-1. PubMed ID: 12547820
    [No Abstract]   [Full Text] [Related]  

  • 18. Signalling by receptor tyrosine kinases.
    Fantl WJ; Johnson DE; Williams LT
    Annu Rev Biochem; 1993; 62():453-81. PubMed ID: 7688944
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of Current Findings about the Role of Oestrogen Receptor α in Cancer Cell Signalling Pathways.
    Voňka P; Hrstka R
    Klin Onkol; 2019; 32(Suppl 3):34-38. PubMed ID: 31627704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New biologies and therapies for breast cancer.
    Cantwell BM
    Ir J Med Sci; 1988 Jul; 157(7):221. PubMed ID: 3170147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.